Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical will pay over $4 billion in opioid settlement

Teva Pharmaceutical Industries Ltd. said it had agreed to pay more than $4 billion to resolve thousands of lawsuits filed against the drugmaker by state and local governments over its highly addictive opioid painkillers.

Tribune News Service

Teva, Allergan Settle Opioid Lawsuit With West Virginia

Teva, Allergan Settle Opioid Lawsuit With West Virginia

U.S. affiliate of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached an agreement with the Attorney General of West Virginia that settles the state's opioid-related claims.

Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients

Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) announced new study findings based on newly established clinical thresholds on short-acting beta-agonist (SABA) use and real-world usage of ProAir Digihaler (albuterol sulfate) inhalation powder. ProAir Digihaler is a breath-actuated, digital SABA inhaler with built-in flow sensors that detect, record, and store objective data. 89% (319/359) of patients…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) and AbbVie Inc's (NYSE:ABBV) Allergan Plc are willing to pay more than $5 billion combined to resolve more than 3,500 lawsuits filed over highly addictive opioid painkillers, according to three people familiar with settlement talks. The people said the companies have been in mediation talks with plaintiffs for more than a year. …

Teva Posts Mixed Q1 Earnings, Cuts FY22 Sales Guidance Citing Copaxone Competition, Yet Shares Rise

Teva Pharmaceutical Industries Ltd's (NYSE:TEVA) Q1 sales reached $3.66 billion, shrinking 8% Y/Y, missing the consensus of $3.75 billion. The decrease is mainly due to lower revenues from generic products in North America and Copaxone, partially offset by higher revenues from Anda and generic products in the Europe segment. The adjusted gross…

San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters

San Francisco will start a trial against Walgreens Boots Alliance Inc (NASDAQ:WBA) and three other companies accused of fueling an opioid crisis in the city. San Francisco has alleged that Walgreens, Teva Pharmaceutical Industries Ltd (NYSE:TEVA), AbbVie Inc's (NYSE:ABBV) Allergan unit, and Teva-owned Anda Inc created a "public nuisance" by flooding the city with prescription opioids and failing…

JNJ, McKesson, Endo Settle $275M Opioid Claims With Alabama: Reuters

Alabama reached $276 million in settlements with Johnson & Johnson (NYSE:JNJ), McKesson Corporation (NYSE:MCK), and Endo International Plc (NASDAQ:ENDP), resolving claims on the opioid addiction crisis, the state attorney general said. McKesson will pay $141 million. JNJ and Endo will pay $70.3 million and $25 million, respectively, Alabama Attorney General Steve Marshall said in a statement. The three…

inkl

Read news from The Economist, FT, and more,
with one subscription

FDA Rejects Teva - MedinCell's Schizophrenia Candidate

FDA Rejects Teva - MedinCell's Schizophrenia Candidate

Teva Pharmaceutical Industries Ltd's (NYSE:TEVA) U.S. affiliate and MedinCell SA (OTC:MDCLF) have received FDA Complete Response Letter (CRL) regarding TV-46000/mdc-IRM for schizophrenia. The drug candidate is risperidone extended-release injectable suspension for subcutaneous use. Teva is reviewing its next steps based on the letter and will work closely with FDA to address their recommendations. Related: Teva Reports…

Rhode Island Announces $107M Opioid Settlements With Teva, Allergan: Reuters

Rhode Island Announces $107M Opioid Settlements With Teva, Allergan: Reuters

Rhode Island's attorney general announced settlements worth $107 million against Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and AbbVie Inc's (NYSE: ABBV) Allergan unit to resolve claims over

35 Generic Drugmakers Sign To Manufacture Low-Cost Version Of Pfizer's COVID Pill

35 Generic Drugmakers Sign To Manufacture Low-Cost Version Of Pfizer's COVID Pill

Thirty-five generic drugmakers will produce low-cost versions of Pfizer Inc's (NYSE:PFE) COVID-19 pill, Paxlovid, to expand supplies of the highly effective drug in lower-income regions. Pfizer struck a deal last year with the group to allow generic drugmakers to make the pills for 95 low- and middle-income countries, covering up to approximately 53% of the…

Rhode Island's Opioid Trial Against Teva Begins Today: Reuters

Rhode Island's Opioid Trial Against Teva Begins Today: Reuters

The first trial in Rhode Island state court against Teva Pharmaceutical Industries Ltd's (NYSE:TEVA) alleged responsibility for the opioid crisis begins jury selection Monday. The case begins over whether Teva contributed to an opioid crisis that has caused more than 500,000 deaths over the past two decades. Rhode Island says Teva created a…

Why Are Teva Pharmaceutical Shares Trading Higher Today?

Why Are Teva Pharmaceutical Shares Trading Higher Today?

Teva Pharmaceutical Industries Ltd's (NYSE: TEVA)

Teva, Texas Enter $225M Opioid Settlement Agreement

Teva, Texas Enter $225M Opioid Settlement Agreement

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached a

People

Patrick Morrisey

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Bloomberg Intelligence

McKesson Corporation

Cardinal Health Inc

CVS Health Corp

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Macular Degeneration

Places

334,338 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play